About Trenzyme
Trenzyme is a Healthcare company based in Konstanz (Germany) founded in 2000. CRO offering gene synthesis, recombinant protein production and customized cell line development services. Trenzyme offers products and services including Stable Cell Line Development Service, Custom Protein Production Services, Stem Cell Characterization Service, High-Throughput Protein Expression Service, and Cell Based Assay Development Service. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Cell and Molecular Biology. Its legal entity is Trenzyme GmbH.
Company details
Trenzyme is a CRO offering molecular biology, custom protein synthesis and purification and customised cell line development services. As part of its molecular biology services, the major offerings are gene synthesis, DNA cloning and mutagenesis. As part of the protein services, they offer exact proteins post purification from microbial, yeast and mammalian expression systems. Their protein yields protein yields range from a few to several hundred mg. As part of their cell line development services, their proprietary ExoIN, ExoINDUCE, and EndoOUT cell culture processes help in assay cell line and production cell line development. They claim to be capable of developing any cellular system as per exact customer requirements through their proprietary cell culture processes. Roche, Lonza and Biocon are some of their reputed customers.
- Headquarters Konstanz, Germany
- SectorsHealthcare
- Website trenzyme.com
- Social LinkedIn X YouTube
- Legal Name Trenzyme Gmbh
- Latest Funding Round$31.49K (USD), Grant
Jun 2019
- Investors
Products & Services of Trenzyme
Trenzyme offers a comprehensive portfolio of products and services, including Stable Cell Line Development Service, Custom Protein Production Services, Stem Cell Characterization Service, High-Throughput Protein Expression Service, and Cell Based Assay Development Service.
Develops stable cell lines for research applications.
Produces tailored proteins using various expression systems.
Characterizes stem cells for differentiation and research needs.
Screens and optimizes protein expression for efficiency.
Develops assays for cell-based phytopharma applications.
Apps and channels of Trenzyme
its YouTube channel trenzyme GmbH has 7 subscribers and 5 videos.
Videos from Trenzyme
The most watched videos on Trenzyme's YouTube channel, trenzyme GmbH (7 subscribers). Click a video to play it here.
More on trenzyme GmbH.
Funding Insights of Trenzyme
- Total Rounds 1
- Last Round Grant — $31,488
- First Round $31,488
(Jun 2019)
- Investors Count 1
All 1 funding rounds of Trenzyme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $31,488 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Trenzyme
Trenzyme has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Trenzyme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Trenzyme
2 dated milestones of Trenzyme across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Trenzyme is founded.
- Funding First funding round of $31K.
Web traffic of Trenzyme
Websites that share an audience with Trenzyme (trenzyme.com).
Websites whose visitors overlap most with Trenzyme. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gerbu.de | 100% | #4,209,132 | View details | ||
| molecularhealth.com | 100% | View details | |||
| veraxa.com | 99% | 4.2K | #4,458,181 | View details | |
brain-biotech-group.com | brain-biotech-group.com | 97% | – | ||
fiz-biotech.de | fiz-biotech.de | 97% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Trenzyme
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Trenzyme
Complete news archive for Trenzyme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trenzyme
Trenzyme was founded in 2000 and raised its 1st funding round 19 years after it was founded.
Trenzyme is headquartered in Konstanz, Germany. It is registered at Konstanz, Baden-wurttemberg, Germany.
Trenzyme is a CRO offering molecular biology, custom protein synthesis and purification and customised cell line development services. As part of its molecular biology services, the major offerings are gene synthesis, DNA cloning and mutagenesis. As part of the protein services, they offer exact proteins post purification from microbial, yeast and mammalian expression systems. Their protein yields protein yields range from a few to several hundred mg. As part of their cell line development services, their proprietary ExoIN, ExoINDUCE, and EndoOUT cell culture processes help in assay cell line and production cell line development. They claim to be capable of developing any cellular system as per exact customer requirements through their proprietary cell culture processes. Roche, Lonza and Biocon are some of their reputed customers.
Trenzyme offers Stable Cell Line Development Service, Custom Protein Production Services, Stem Cell Characterization Service, High-Throughput Protein Expression Service, and Cell Based Assay Development Service.
Trenzyme has 1 investor. Key investors include European Union.
Trenzyme operates through Trenzyme Gmbh.